BUZZ-U.S. STOCKS ON THE MOVE-Joy Global, Second Sight, Encana

Thu Mar 5, 2015 9:15am EST
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article | Single Page
[-] Text [+]

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter,; for the Morning News Call newsletter, U.S. stock index futures edged up on Thursday, after two days of declines on the S&P 500, ahead of data on the labor market and factory orders. Dow Jones industrial average e-mini futures were up 0.19 percent at 18,121, S&P 500 e-mini futures were up 0.19 percent at 2,100.5 and Nasdaq 100 e-mini futures were up 0.22 percent at 4,454.

** ABBVIE INC, Wednesday close $60.27, -4.68 pct premarket

** PHARMACYCLICS INC, Wednesday close $230.48, +10.68 pct premarket

AbbVie will buy Pharmacyclics for about $21 billion, giving it access to what is expected to be one of the world's top-selling cancer drugs and expanding its reach in the profitable oncology field. The deal, the latest example of a big drugmaker swooping on a biotech firm to refill its medicine pipeline, confounds expectations that Pharmacyclics would sell out to Johnson & Johnson.

** ARROWHEAD RESEARCH CORP, Wednesday close $7.51, +11.45 pct premarket

The drug developer said it acquired Novartis AG's RNAi assets, including various patents and three preclinical drugs.